| ACLARION NEW DL-,00001 |
| USA |
| Gesundheit |
| US6551874091 / A412BH |
| IT20 (Frankfurt) / ACON (NASDAQ) |
| FRA:IT20, ETR:IT20, IT20:GR, NASDAQ:ACON |
| - |
| https://aclarion.com/ |
|
Aclarion, Inc. is a healthcare technology company focused on using magnetic resonance spectroscopy and proprietary signal-processing biomarkers to support the evaluation of spine-related pain. Its core product, Nociscan, is a cloud-based software pla..
>Volltext.. |
| 6.55 Mio. EUR |
| -7.76 Mio. EUR |
| 0.07 Mio. EUR |
| -8.31 Mio. EUR |
| -8.07 Mio. EUR |
| -6.67 EUR |
| - |
| 14.32 Mio. EUR |
| -7.1 Mio. EUR |
| 15.73 |
| 33.07% |
| -31.49% |
| - |
| - |
| - |
| - |
| ACLARION |
| 29.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|